Transaction in Own Shares

Summary by AI BETAClose X

GSK plc announced the purchase of 276,710 of its ordinary shares, each with a nominal value of 31¼ pence, on September 5, 2025. The shares were bought through Merrill Lynch International, acting as its corporate stockbroker. The lowest price paid per share was 1,463.00 GBp, while the highest price reached 1,477.50 GBp, with a volume-weighted average price of 1,472.87 GBp. These shares will be held as treasury shares as part of an existing buyback program, bringing the total purchased since June 4, 2025, to 27,592,177 ordinary shares. Following this transaction, GSK holds 245,726,560 ordinary shares in treasury, with 4,069,675,167 ordinary shares in issue, excluding treasury shares; the treasury shares represent 6.04 percent of voting rights.

Disclaimer*

Companies

GSK (GSK)
UK 100

Latest directors dealings